Categories AlphaGraphs, Consumer, Earnings

MKC Earnings: Highlights of McCormick & Company’s Q2 2023 financial results

McCormick & Company, Inc. (NYSE: MKC), a manufacturer and distributor of seasoning mixes and other flavorful products, announced financial results for the second quarter of 2023, reporting higher earnings and revenues.

McCormick & Company, Incorporated Q2 2023 earnings infographic

Second-quarter sales increased 8% year-over-year to $1.66 billion. The Consumer and Flavor Solutions segments grew 5% and 11%, respectively.

Net income increased to $152.1 million or $0.56 per share in Q2 from $118.5 million or $0.44 per share in the corresponding period of 2022. On an adjusted basis, the company reported earnings of $0.60 per share, up 25%.

Looking ahead, the management expects adjusted earnings per share to be in the range of $2.60 to $2.65 in fiscal 2023, higher than the previously reported guidance of $2.56-$2.61 per share.

Prior Performance

  • McCormick-Q4-2022-Earnings-Infographic
  • McCormick-Q3-2022-Earnings-Infographic
  • McCormick & Company Q2 2022 earnings infographic

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Nike (NKE) looks set to beat hurdles and build a brighter future

Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business

Electronic Arts (EA): A few points to keep in mind if you have an eye on this gaming company

Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as

Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor

Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top